PTGX
Protagonist Therapeutics Inc.
$64.51
+$2.31(+3.71%)
37
Overall
35
Value
40
Tech
--
Quality
Market Cap
$3.64B
Volume
702.60K
52W Range
$33.31 - $63.30
Target Price
$69.69
EPS Estimates Overview
| Current Quarter | $-0.59 | Next Quarter | $-0.54 |
| Current Year | $-1.86 | Next Year | $0.08 |
| QoQ Growth | +8.5% | YoY Growth | +104.3% |
| 3Y EPS CAGR | +54.0% | Target Price | $69.69 |
| Consensus | Buy | Upside | +8.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $64.51 | +3.7% | 702.60K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW